Healthcare Costs in the U.S.: An Unfolding Crisis

In the U.S., rising healthcare costs pose a significant challenge for many citizens. Despite discussions around potential solutions, like Medicare-for-All, there are complexities that may hinder effective change. This article delves into current issues affecting healthcare expenses, particularly the impact of high-cost medications and the systemic challenges faced by large healthcare purchasers.

Yves here. While this article accurately highlights the alarming surge in healthcare costs in the United States, it unfortunately overstates how effective a Medicare-for-All system would be as a remedy. Consider the approach taken by the Australian Therapeutic Goods Administration (TGA), which is a considerably smaller drug purchaser. The TGA staff diligently examines medical research, subsequently selecting a single medication for most conditions. They frequently dismiss newer advancements, like once-a-day slow-release versions of drugs, if they don’t significantly enhance health outcomes. Such newer formulations, however, can prolong patent life, maintaining high retail prices.

By consolidating their orders for fewer medications, the TGA negotiates significantly larger purchases, allowing them to drive harder bargains.

One might argue that this leads to reduced options. Yet, the trade-off results in more effective medications at drastically lower prices compared to those experienced in the U.S.

Praising Medicare and other substantial buyers of medical services in the U.S. neglects the reality that they often find themselves as price-takers—or worse, pawns in the corrupt system that is Pharmacy Benefit Managers.

The article briefly touches on a crucial point: the stark increase in private insurance costs is largely driven by astronomical cancer treatment expenses and high-priced GLP-1 medications, such as Ozempic and Wegovy.

So, what has Medicare proposed to address these soaring costs? Implementing restrictions such that many patients are unable to access these treatments. An email from IM Doc elaborates:

This issue may not receive the same level of attention as international conflicts, but it is inciting widespread anger among everyday citizens.

Imagine being bombarded with advertisements across social media and television for four years featuring various individuals taking a miraculous new drug for weight loss, GLP-1s. You visit your doctor to obtain a prescription only to find it priced at $1,400 per month, a cost that wasn’t even that high a few months prior, with neither your insurance nor Medicare covering a cent. Understand the frustration.

Then comes relief with an announcement that Medicare will begin to cover these drugs on July 1. Ads flood in, featuring Trump proclaiming they are “FREE.” Yet, once your doctor receives the eligibility criteria for the “Medicare GLP-1 Bridge Program,” the reality sets in: the exclusion criteria essentially cut out 95% of the population. In practice, if you have or ever had sleep apnea, you’re disqualified. Given the high prevalence of obstructive sleep apnea among obese patients, this criterion effectively leaves many without access.

This strikes as incredibly inept, and the widespread frustration is astonishing. This situation represents one of the more significant missteps in the pharmaceutical sector, with Trump rightfully bearing much of the blame.

Just thought you’d like to be informed. When possible, I’ll share the CMS documents sent to practicing MDs.

I didn’t request any supplementary documents, but I am certain they would provide a fascinating narrative.

The deeper issue reflects that many Americans are not in the best of health due to poor dietary habits, excessive stress, lack of physical activity, and suboptimal sleep patterns. Additionally, many rely on psychoactive medications to navigate our precarious and exploitative system. Long-term usage of these drugs often leads to health complications, such as the typical 10-20 pound weight gain seen with SSRIs. The push for a healthier America resonates strongly, despite the myriad questionable health trends that often accompany it. Creating a healthier workforce could stem from ending precarious work schedules for lower-income individuals and unrealistic 24/7 on-call expectations for those in higher-paying roles. More free time could foster engagement in social activities, exercise, family care, and healthier home-cooked meals—if we can break free from the neoliberal “no rights for labor” mentality.

By Brett Wilkins, staff writer at Common Dreams. Originally published at Common Dreams

Workers in the U.S. with employer-based health insurance are projected to spend an average of $5,297 on healthcare this year, encompassing premiums, deductibles, and copayments, according to a new estimate by benefits consulting leader Aon, as reported by The Wall Street Journal

.

This figure reflects a $388 increase from the previous year, and trends indicate that the financial strain is likely to worsen by 2027. A survey by WTW forecasts a staggering 11.1% rise in healthcare costs for U.S. employers in the upcoming year, marking the steepest increase observed in over two decades and continuing a five-year trend of escalating employer health expenditures.

As the Journal notes, the skyrocketing costs are being driven in part by exorbitant cancer treatments and the wide adoption of weight loss drugs. For employees, this translates into greater deductions from paychecks, increased out-of-pocket expenses, and, for some, even the abandonment of health insurance altogether.

“Employers are telling us that this is utterly unsustainable,” stated Jeff Levin-Scherz, WTW’s population health leader, in an interview with the Journal.

Jason Wilburn, co-owner of Paul Wissmach Glass Co. in Paden City, West Virginia—employing 35 people—has faced annual double-digit premium increases since 2021, with healthcare now consuming 5% of the company’s revenue, surpassing their profit margin percentages.

To manage these costs, Wissmach Glass Co. increased its biweekly payroll deduction from $40 to $50 per worker, even though the company covers approximately 90% of the total premium. This increase has compelled some employees to drop their health coverage.

“It’s frustrating and sad,” Wilburn lamented to the Journal. “Something has to change.”

Democrats cited this report in a statement Thursday, emphasizing that President Donald Trump and Republicans have exacerbated healthcare costs for millions of Americans.

“Initially, they slashed Medicaid by nearly $1 TRILLION—the largest healthcare cut in history—to fund tax cuts for the wealthy,” they stated, referencing Trump’s signature One Big Beautiful Bill Act. “Afterward, they ignored the necessity of extending enhanced Affordable Care Act premium tax credits, driving up premiums by an average of 58%.”

“Trump and Republicans’ cuts have already forced 3 million individuals to forfeit their insurance, with many more expected to follow as premiums are set to experience another double-digit surge next year,” their statement continued. “More than half of Americans are already unable to reliably afford healthcare in 2025—a noteworthy decline over five years—and nearly 1 in 4 American workers reports remaining in undesirable jobs solely to retain consistent health insurance.”

“Trump’s relentless cuts to healthcare have inflated costs for millions of Americans,” asserted Democratic National Committee spokesperson Jaelin O’Halloran. “Everyday people are draining their savings and accruing record levels of debt just to afford a doctor’s visit or essential medications—and Trump seems indifferent.”

“While Trump focuses on personal projects and tax breaks for the affluent, working families are struggling to pay healthcare bills or skipping coverage due to affordability, and they will hold Trump and Republicans accountable come November,” O’Halloran added, pointing to the upcoming midterm elections.

While progressives advocate for uncoupling health insurance from employment, Democratic leaders remain hesitant to endorse Medicare for All or any universal healthcare models. Just this week, House Minority Leader Hakeem Jeffries (D-NY) reaffirmed his opposition to Medicare for All, which contradicts the sentiments of 90% of surveyed Democratic voters in a recent CBS/YouGov poll.

As reported by Common Dreams, a recent study from Yale University indicated that Medicare for All, as proposed in legislation introduced by Sen. Bernie Sanders (I-Vt.) and Reps. Pramila Jayapal (D-Wash.) and Debbie Dingell (D-Mich.)—could potentially save over 114,000 lives annually and reduce U.S. healthcare expenditures by $1 trillion each year.

Rep. Ro Khanna (D-Calif.) referenced this study in a recent interview, challenging Jeffries’ position.

“Medicare for All is arguably our most critical priority,” Khanna stated, urging a vote on Sanders’ bill. “It promises savings and the potential to save lives.”